HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wim Van den Broeck Selected Research

Wim Van den Broeck Research Topics

Disease

12Infections
01/2022 - 09/2002
1COVID-19
11/2021
1Coronavirus Infections
01/2020
1Viremia
01/2019
1Coinfection
12/2015
1Hyperplasia
12/2013
1Aneuploidy (Aneuploid)
08/2008

Drug/Important Bio-Agent (IBA)

1ExotoxinsIBA
01/2022
1Bacterial ToxinsIBA
01/2022
1NucleotidesIBA
11/2021
1Sialic AcidsIBA
01/2020
1Neuraminidase (Sialidase)IBA
01/2020
1CD13 Antigens (Alanine Aminopeptidase)IBA
01/2020
1deoxynivalenolIBA
07/2019
1fumonisin B1IBA
07/2019
1Vehicle Emissions (Emissions, Vehicle)IBA
07/2019
1Aflatoxin B1 (Aflatoxin B)IBA
07/2019
1Glycoproteins (Glycoprotein)IBA
01/2019
1Peptide Hydrolases (Proteases)FDA Link
01/2019
1Viral ProteinsIBA
01/2019
1Neutralizing AntibodiesIBA
01/2019
1Egtazic Acid (EGTA)IBA
11/2017
1Acetylcysteine (Siran)FDA LinkGeneric
11/2017
1Polysaccharides (Glycans)IBA
11/2017
1Enterotoxins (Enterotoxin)IBA
12/2015
1Mucin-4IBA
12/2015
1AcidsIBA
12/2013
1Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
12/2013
1GlucansIBA
08/2012
1Prostaglandins DIBA
08/2008

Therapy/Procedure

2Oral Administration
07/2008 - 09/2002
1Investigational Therapies (Experimental Therapy)
01/2019
1Therapeutics
01/2011